Skip to Content

Committed to Safety: We are taking all necessary precautions to keep you safe while we care for you. Review all our visitor policies and precautions. Get more information on COVID-19.

Interested in applying for a pharmacy residency?

Fill out this form to get more information from a member of our pharmacy team!

Follow us on Facebook and Instagram @mcpharmacyresidency


Publications

  • Kim J, Powers S, Rice C, Cawley P. Interprofessional medication self-management program for older underserved adults. Patient Prefer Adherence. 2020:14;839-845.

  • Barnes JN, Ton M, Dunham S, Wadsworth D, Sprague T, Kim J. Diabetes management part 1: Everything insulin. Tl;dr pharmacy. 2019 June 17. https://www.tldrpharmacy.com/content/diabetes-management-part-1-everything-insulin.

  • Barnes JN, Ton M, Dunham S, Wadsworth D, Sprague T, Kim J. Diabetes management part 2: Building a regimen. Tl;dr pharmacy. 2019 July 3. https://www.tldrpharmacy.com/content/diabetes-management-part-2-building-a-regimen.

  • Evaluation of the Accuracy of Different Methods Used to Estimate Ideal Body Weight in the Pediatric Population J Pediatr Pharmacol Ther 2019;24(5):421-430 - Kenny Kang, Randy Absher, Elizabeth Farrington, Renee Ackley and Tsz- Yin So
  • A Review on the Use of Cystic Fibrosis Transmembrane Conductance Regulator Gene Modulators in Pediatric Patients. J Pediatr Health Care 2019; 33:356-364 - Michael Bitonti, Laura Fritts and Tsz-Yin So
  • The Use of Codeine and Tramadol in the Pediatric Population – What is the Verdict Now? J Pediatr Health Care 2019;33:117-123 - Megan Fortenberry, Justin Crowder and Tsz-Yin So
  • A Literature Review on the Use of Dornase Alfa in Pediatric Patients with Lower Respiratory Tract Illnesses other than Cystic Fibrosis. Arch Pediatr Neonatol 2018;1(1):26-35 - Radha Patel and Tsz-Yin So
  • Evaluation of the Efficacy of a Onetime Injectable Dexamethasone Administered Orally in the Pediatric Emergency Department for Asthma Exacerbation. J Pediatr Pharmacol Ther 2017;22(5):326-331 - McCallister A, So TY. 
  • Treatment of Pediatric Clostridium difficile Infection: A Review on Treatment Efficacy and Economic Value. Infect Drug Resist 2017;10:365-375 - D’Ostroph AR, So TY. 
  • Assessing Medication Adherence at a Student-Run Free Health Clinic.  Journal of Student Run Free Clinics. Vol 3 No 1. Sept 17, 2017. - Lam FW, Kaplan MC, Gazda NP, Shah MD, Toler JA, Scolaro, KL. 
  • Impact of Developing Adult Ketamine Order Panels for the Emergency Department. Hosp Pharm 2017;1-5 - Baird H, Rumbarger R. 
  • Real-world Experience with Oritavancin Therapy in Invasive Gram-Positive Infections. Infect Dis Ther 2017;6:277-289 - Stewart C, Turner M, Frens J, Snider C, Smith J.  
  • Elements of Success for Transitioning to the Role of Director of Pharmacy. Am J Health Syst Pharm 2017;74:557-561 - Granko RP, Thompson JM, Morton CS, Little JD. 
  • Comparison of Two Medication Therapy Management Practice Models on Return on Investment. J Pharm Pract 2017;30(3):282-285 - Gazda NP, Ferreri S. Berenbrok L. 
  • Strategy for Pharmacy Data Management. Am J Health Syst Pharm 2017;74:79-85 - Wolfe A, Hess L, La MK, Pappas AL, Moore R, Granko RP, Daniels, R. 
  • Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population. Clin Drug Investig 2017; 37(7):625-634 - Corey A, So TY. 
  • Primary Immunization of Human Papillomavirus Vaccine in the Pediatric Population – What Is the Verdict Now? Clin Pediatr (Phila) 2017;56(7):605-615 - Jones AN, Barlett JW, Bates RA, So TY. 
  • The Use of Citrulline for Pediatric Pulmonary Hypertension. Res J Clin Pediatr 2017;1:1-6 - Yang S, So TY. 
  • Pharmacy Practice: Exploring the Relationship between SSRIs and Sodium Levels in an Older Adult Population. Inov Pharm. 2016;7(4): Article 14. - Anderson SL, Johnston N. 
  • Pharmacists’ Impact on Opportunistic Infection Prophylaxis in Patients with HIV/AIDS. J Hosp Infect 2016;94(4):389-392 - Schatz K, Guffey W, Maccia M, Templin M, Rector K. 
  • Medication Use Evaluation of Dronedarone in Comparison to Amiodarone. Inov Pharm2016;7(4): Article 18. - Corey A, Johnston N. 
  • Medication Reconciliation Limitations: Observation of the Medication Reconciliation Process in the Emergency Department by Two Immersion Pharmacy Students. Inov Pharm2016;7(4): Article 4. - Chong C, Haile A. 
  • Medication Adherence Survey: A First Year Pharmacy Immersion Students’ Perspective. Inov Pharm. 2016;7(3): Article 8. - Ortiz Lopez CF, Li M, Johnston N. 
  • Patient Medication Use: Interpreting the Results of a Patient Medication Safety Survey by Phase I Immersion Pharmacy Students. Inov Pharm2016;7(3): Article 4. - Li M, Ortiz Lopez CF, Johnston N, et al. 
  • Attention Deficit Hyperactive Disorder and Occurrence of Tic Disorders in Children and Adolescents-What is the Verdict Now? Curr Pediatr Rev. 2016;12(3):230-238 - Cooke T, So TY. 
  • Standardize Practice to Identify IV Errors. Pharmacy Purchasing and Products, May 2016, page 20 - Granko RP, McCallister A. 
  • Transitioning antimicrobials from intravenous to oral in pediatric acute uncomplicated osteomyelitis. World J Clin Pediatr 2016; 5(3): 244-250 - Batchelder N, So TY. 
  • Hypersensitivity Reaction to Insulin Glargine and Insulin Detemir in a Pediatric Patient: A Case Report. J Pediatric Pharmacol Ther. 2016;21(1):85-91 - Badik J, Chen J, Letvak K, So TY.  
  • Current Clinical Trials on the Use of Direct Oral Anticoagulants in the Pediatric Population. Cardio Ther 2016;5(1):19-41 - von Vajna E, Alam, R, So TY. 
  • The Use of Penicillin for the Prevention of Pneumococcal Infection in Pediatric Patients with Sickle Cell Disease. J Pediatr Sci 2015;7:e246 - Lawuyi B, Basham J, So TY. 
  • The Risk of Musculoskeletal Adverse Events with Fluuroquinolones in Children: What is the Verdict Now? Clin Pediatr 2016; 55(2):107-110 - Binz J, Adler C, So TY. 
  • Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease. J Pediatric Pharmacol Ther. 2015;20(3):163-177 - Saneeymehri S, Baker K, So TY. 
  • Promoting Pharmacy Business Success through the Implementation of a Departmental Operating Review Series. Am J Health Syst Pharm 2015; 72:610-613 - Granko RP, Lamm M. 

  • Assessing the Personal Performance And Professional Self-development Potential of a Pharmacy Management Practitioner. Am J Health Syst Pharm 2015; 72:149-157 - Granko RP, Wolfe A, Morton C, et.al.
  • Ali A, Kim JJ, Pisano M. Beta adrenergic antagonists and antianginal drugs. Side Effects of Drugs Annual. 2019;41:197-205.

  • Bui A, Kwon J, Kim J, Lucas A. Overcoming barriers to statin adherence. U.S. Pharm. 2019 June;19-22. Medscape: https://www.medscape.com/viewarticle/915570.

  • Tillman F, Kim JJ, Osae L, Makhlouf T. Heart failure treatment in African Americans. Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719840192.

  • Vincent R, Kim JJ, Patel V, Ahmed T. Pharmacist initiative to increase statin prescribing in diabetes patients. J Pharm Pract. 2019 Jan 29:1-7.

  • Ali A, Kim JJ, Pisano M, Hudgins DK, Wireku M, Ray SD. Beta adrenergic antagonists and antianginal drugs. Side Effects of Drugs Annual. 2018;40:243-252.

  • Koval P, Kim JJ, Makhlouf TK. Perceptions of a mobile application audience response system for remote pharmacy continuing education participants. J Pharm Pract. 2018 Aug:1-5.

  • Tillman F III, Kim J. Select medications that unexpectedly lower HbA1c levels. J Clin Pharm Ther. 2018 Aug;43(4):587-590.

  • Kim JJ, Combs K, Downs J, Tillman F. Medication adherence, the elephant in the room. U.S. Pharm. 2018;43(1):30-34.

  • Aguilar C, Sartori M, D'Angelo A, Kabrhel C, Groce J, et al. Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study. DiET Study Group. Blood Coagul Fibrinolysis. 2018 Sep;29(6):562-566.

  • Kim JJ, Hill HL, Groce JB 3rd, Granfortuna JM, Makhlouf TK. Pharmacy Student Monitoring of Direct Oral Anticoagulants. J Pharm Pract. 2018 Oct;31(5):462-468.

  • Wild, D. Featuring Combs K, Kim JJ, Gazda N. Optimizing opioid prescribing. ASHP Intersections: http://www.ashpintersections.org/2019/01/pharmacists-teach-medical-residents-how-to-optimize-opioid-prescribing/.

  • Combs K, Kim JJ, Gazda N. Pharmacist intervention to monitor and reduce opioid use in patients with chronic non-cancer pain as part of an interdisciplinary pilot monitoring program. 2018. ASHP Resources: https://www.ashp.org/Membership-Center/Member-Spotlight-Gallery/Opioid-Case-Study-Cone-Health-Greensboro-North-Carolina.

  • Kirk JK, Edwards R, Brewer A, Miller C, Bray B, Groce JB. Overview of a pharmacist anticoagulation certificate program. Curr Pharm Teach Learn. 2017 Jul;9(4):707-712.

  • Combs K, Kim JJ. Let’s talk: medication adherence. Pharmacy Times. 2017 Jul. http://www.pharmacytimes.com/future-of-pharmacy/lets-talk-medication-adherence.

  • Corey A, Kim JJ. Prescribing patterns of statin therapy compared to American Diabetes Association Standards of Care at an academic internal medicine center. NC Pharmacists Journal. 2017 Spring;97(2):32-36.

  • Kim JJ, D’Ostroph A. Tips for managing adverse drug reactions. Pharmacy Times. 2017 Jan. http://www.pharmacytimes.com/future-of-pharmacy/tips-for-managing-adverse-drug-reactions.

  • Ali A, Kim JJ, Pisano M, Goad N. Drugs That Affect Lipid Metabolism. Side Effects of Drugs Annual. 2017;39:457-464.

  • Lee SC, Groce JB III, Kim JJ. A pilot process to identify and switch high-risk warfarin patients to direct oral anticoagulants. J Hosp Admin. 2017 Sep 18;6(5):20-26.